Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Prostate-Specific Antigen Screening for High-risk Insured Men Act or the PSA Screening for HIM Act This bill requires private health insurance plans to cover preventive prostate cancer screenings that are not already covered under the recommendations of the U.S. Preventive Services Task Force for men with a family history of prostate cancer, without imposing any cost-sharing requirement.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2022 · fourth_quarter · Health Issues
Support for H.R. 1176 - PSA Screening for HIM Act.
Client expense: Not reported · Firm income: $40,000
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening HR 7750 - Prostate Cancer Community Assistance, Research and Education Act of 2021 to create a committee to coordinate prostate cancer research across federal agencies.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening HR 7750 - Prostate Cancer Community Assistance, Research and Education Act of 2021 to create a committee to coordinate prostate cancer research across federal agencies.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues related to FDA regulatory pathways for pharmaceuticals; Issues related to pharmaceutical pricing, health care cost and price transparency: H.R. 3 - "Elijah E. Cummings Lower Drug Costs Now Act"; H.R. 19 - "Lower Costs, More Cures Act"; S. 2164 - "Lower Costs, More Cures Act."; Issues related to health care and prescription drug pricing in H.R. 5376 - "Build Back Better Act"; H.R. 5801 - HELP Copays Act. HR 7506 - "New Era of Preventing End-Stage Kidney Disease Act." S. Res 683 and H.R. 1176 - Recognizing World Sickle Cell Awareness Day.
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening HR 7750 - Prostate Cancer Community Assistance, Research and Education Act of 2021 to create a committee to coordinate prostate cancer research across federal agencies. HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments HR 5558 - The Prostate Cancer Prevention Act - concerning prostate cancer screening and related activities at the CDC
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $135,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening Not-yet-introduced Prostate Cancer Community Assistance, Research and Education Act of 2021 to create a committee to coordinate prostate cancer research across federal agencies. HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $135,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening Not-yet-introduced Prostate Cancer Community Assistance, Research and Education Act of 2021 to create a committee to coordinate prostate cancer research across federal agencies. HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $95,679 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments
Client expense: $95,679 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening
Client expense: $99,737 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening Not-yet-introduced Prostate Cancer Community Assistance, Research and Education Act of 2021 to create a committee to coordinate prostate cancer research across federal agencies.
Client expense: $99,737 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening
Client expense: $84,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2021 · second_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening Medicare coverage for brachytherapy for prostate cancer
Client expense: $84,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2021 · first_quarter · Insurance
HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening
Client expense: $75,425 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2021 · first_quarter · Health Issues
HR 1176 - The PSA Screening for HIM Act, to increase access to prostate cancer screening
Client expense: $75,425 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
| Democratic |
| CA |
| Bennie G. Thompson | Democratic | MS |
| Bradley Scott Schneider | Democratic | IL |
| Brian Babin | Republican | TX |
| Brian K. Fitzpatrick | Republican | PA |
| Cynthia Axne | Democratic | IA |
| Darren Soto | Democratic | FL |
| David Scott | Democratic | GA |
| Donald M. Payne, Jr. | Democratic | NJ |
| Doris O. Matsui | Democratic | CA |
| Eleanor Holmes Norton | Democratic | DC |
| G. K. Butterfield | Democratic | NC |
| Greg Pence | Republican | IN |
| Gwen Moore | Democratic | WI |
| J. Luis Correa | Democratic | CA |
| Jahana Hayes | Democratic | CT |
| Jefferson Van Drew | Republican | NJ |
| Jimmy Gomez | Democratic | CA |
| Judy Chu | Democratic | CA |
| Kweisi Mfume | Democratic | MD |
| Larry Bucshon | Republican | IN |
| Lisa Blunt Rochester | Democratic | DE |
| Marc A. Veasey | Democratic | TX |
| Melanie A. Stansbury | Democratic | NM |
| Mondaire Jones | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Rashida Tlaib | Democratic | MI |
| Raúl M. Grijalva | Democratic | AZ |
| Roger Williams | Republican | TX |
| Ruben Gallego | Democratic | AZ |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Sharice Davids | Democratic | KS |
| Steve Cohen | Democratic | TN |
| Tim Ryan | Democratic | OH |
| Troy A. Carter | Democratic | LA |